# ROSWELL PARK CANCER INSTITUTE CORP: A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ROSWELL PARK CANCER INSTITUTE CORP |
| Location | BUFFALO, NY |
| Project | A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors |
| Project number | 5R01CA281862-04 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $755,795 |
| Awarded | 2026-09-11 |
| Project period | 2023-09-14 to 2028-08-31 |
| UEI | YDWAYVVQHNK5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11401364). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.